Journal of Artificial Intelligence and Digital Health

INTRODUCTION

The growing complexity of biomedical and environmental challenges has necessitated the development of integrated scientific approaches that transcend traditional disciplinary boundaries. In this context, the convergence of nanotechnology, biotechnology, and artificial intelligence (AI) has emerged as a powerful paradigm for addressing limitations in conventional diagnostic, therapeutic, and environmental management systems [1]. This convergence is not merely additive but synergistic, producing novel functionalities that cannot be achieved by each field independently.

One of the central drivers of this integration is the increasing availability of high-dimensional biological and environmental data. Modern sequencing technologies, imaging systems, and sensor networks generate vast datasets that require advanced computational tools for meaningful interpretation [2]. AI, particularly machine learning and deep learning models, plays a critical role in extracting patterns, predicting outcomes, and supporting decision-making processes in complex biological environments. However, AI systems require accurate and high-quality input data, which is often dependent on advancements in nanotechnology and biotechnology.

Nanotechnology provides the physical interface between biological systems and computational models. By engineering materials at the nanoscale, researchers can design highly sensitive biosensors capable of detecting molecular changes at extremely low concentrations [3]. These nanosensors enhance early disease detection, environmental monitoring, and real-time diagnostic systems. Additionally, nanoparticle-based drug delivery systems enable targeted therapy, improving drug efficiency while reducing off-target effects and toxicity [4].

Biotechnology complements these advancements by enabling the manipulation of biological systems at the genetic and molecular levels. Techniques such as gene editing, recombinant DNA technology, and synthetic biology have expanded the ability to design customized biological systems for specific therapeutic and environmental applications [5]. Bioengineered systems can be designed to respond to specific stimuli, enabling controlled therapeutic responses in precision medicine frameworks.

The integration of AI with these biological and nanoscale systems enhances their functionality significantly. AI algorithms can optimize nanoparticle design, predict biological interactions, and simulate drug-target binding with high accuracy [6]. In drug discovery, AI reduces the dependency on time-consuming laboratory experiments by narrowing down potential candidate molecules through computational screening. This accelerates the research and development pipeline while reducing associated costs.

In environmental science, the Nano–Bio–AI integration offers innovative solutions for pollution control and ecosystem restoration. Nanomaterials can be engineered to capture or degrade pollutants, while biological systems such as microbes can be enhanced through genetic modification to break down hazardous substances [7]. AI systems further improve these processes by modeling environmental conditions, predicting pollutant behavior, and optimizing remediation strategies. This integrated approach supports sustainable environmental management and climate resilience.

Another important dimension of this convergence is the development of intelligent biomedical systems capable of autonomous operation. These systems combine nanosensors, biological feedback mechanisms, and AI-driven decision-making to monitor physiological conditions in real time [8]. Such systems have significant applications in chronic disease management, cancer therapy, and personalized healthcare. For example, smart drug delivery platforms can release therapeutic agents in response to specific biological triggers such as pH changes, enzyme activity, or temperature variations.

Despite these advancements, several scientific and technical challenges must be addressed. One of the major concerns is the biocompatibility and long-term toxicity of nanomaterials [9]. While nanotechnology offers significant advantages in medical applications, unintended interactions with biological systems may lead to adverse effects. Similarly, AI systems face challenges related to data bias, interpretability, and ethical decision-making in healthcare applications. Biotechnology also raises concerns regarding genetic modification and its long-term ecological impact.

Another challenge lies in the integration of heterogeneous data sources across biological, computational, and environmental domains. Effective Nano–Bio–AI systems require standardized data formats, interoperable platforms, and robust validation frameworks [10]. Without these, the potential of integrated systems may remain limited to theoretical applications rather than practical implementation.

Furthermore, ethical and regulatory frameworks must evolve alongside technological advancements. The use of AI in healthcare decision-making raises questions about accountability and transparency, while nanobiotechnology introduces concerns regarding environmental release and bioaccumulation [11]. Addressing these issues requires collaboration among scientists, policymakers, and regulatory bodies to ensure safe and responsible innovation.

In conclusion, the integration of nanotechnology, biotechnology, and artificial intelligence represents a transformative shift in scientific research and application. By combining molecular engineering, biological systems, and computational intelligence, this multidisciplinary framework offers unprecedented opportunities for innovation in medicine and environmental science. Continued research in this field is expected to lead to the development of highly intelligent, adaptive, and sustainable systems capable of addressing some of the most pressing global challenges.

LITERATURE REVIEW

The integration of nanotechnology, biotechnology, and artificial intelligence (AI) has attracted significant research attention due to its potential to transform biomedical and environmental systems. Existing literature demonstrates that each of these domains has independently contributed to major scientific advancements; however, recent studies emphasize the importance of their convergence for achieving higher efficiency and innovation [12].

Nanotechnology has been extensively studied for its applications in drug delivery, diagnostics, and environmental remediation. Early work by researchers such as Mauro Ferrari highlighted the potential of nanoparticles in targeted cancer therapy, where nanoscale carriers improve drug localization and reduce systemic toxicity [13]. More recent studies have focused on the development of multifunctional nanomaterials capable of simultaneous diagnosis and treatment, often referred to as theranostic systems. These advancements demonstrate the growing importance of nanotechnology in precision medicine and environmental monitoring.

Biotechnology has similarly evolved with the development of advanced molecular and genetic engineering techniques. Research in synthetic biology and gene editing has enabled the design of bio-responsive systems that can interact dynamically with biological environments [14]. These systems are particularly useful in applications such as regenerative medicine, vaccine development, and microbial-based environmental remediation. Studies have shown that engineered microorganisms can effectively degrade pollutants, providing sustainable solutions for environmental challenges.

Artificial intelligence has emerged as a critical tool for analyzing complex biological and environmental data. Machine learning algorithms are widely used in genomics, proteomics, and drug discovery to identify patterns and predict outcomes with high accuracy [15]. AI-based systems have been shown to significantly reduce the time required for drug discovery by identifying potential therapeutic compounds through computational modeling. Furthermore, AI enhances diagnostic capabilities by improving image analysis and disease prediction accuracy.

Recent literature highlights the increasing convergence of these three domains. Integrated Nano–Bio–AI systems combine the strengths of each field to create intelligent and adaptive solutions [16]. For example, AI can be used to design and optimize nanomaterials, while biotechnology ensures biological compatibility and functional performance. This integration enables the development of systems capable of sensing, analyzing, and responding to biological signals in real time.

In environmental science, studies have demonstrated the effectiveness of combining nanotechnology and biotechnology for pollutant degradation. Nanomaterials enhance the efficiency of microbial systems, while AI optimizes environmental monitoring and remediation strategies [17]. This integrated approach has been applied in water purification, soil remediation, and air quality monitoring, showing promising results in improving environmental sustainability.

Despite these advancements, the literature also identifies several challenges associated with Nano–Bio–AI integration. One major issue is the lack of standardized frameworks for integrating data from different domains [18]. Biological, chemical, and computational datasets often differ in structure and scale, making integration complex. Additionally, concerns related to nanotoxicity and biosafety remain significant barriers to large-scale implementation.

Ethical considerations in AI applications are also widely discussed in the literature. Issues such as data privacy, algorithmic bias, and transparency in decision-making processes must be addressed to ensure responsible use of technology [19]. Furthermore, regulatory frameworks for nanobiotechnology are still evolving, highlighting the need for interdisciplinary collaboration and policy development.

Overall, the literature indicates that while significant progress has been made in each individual domain, the true potential lies in their integration. The Nano–Bio–AI framework represents a promising direction for future research, offering innovative solutions for complex biomedical and environmental challenges. Continued advancements in this field are expected to lead to more efficient, sustainable, and intelligent systems.

METHODOLOGY (INTEGRATED NANO–BIO–AI FRAMEWORK)

This study adopts a conceptual and analytical framework methodology to examine the integration of nanotechnology, biotechnology, and artificial intelligence (AI) for biomedical and environmental applications. The approach is based on systematic literature synthesis, comparative technology analysis, and framework modeling to develop a unified Nano–Bio–AI system [20]. The methodology is designed to highlight functional interactions among the three domains rather than relying on a single experimental dataset, making it suitable for review and theoretical framework publication.

Research Design

• This study adopts a hybrid research design comprising a PRISMA 2020-guided systematic literature review (SLR) and conceptual framework development. The systematic review was undertaken to identify, evaluate, and synthesize current peer-reviewed evidence on the integration of nanotechnology, biotechnology, and artificial intelligence (AI) in biomedical and environmental applications. The conceptual framework was subsequently developed by integrating recurring themes, technological interactions, and functional relationships identified from the synthesized literature.
• The systematic review component provides a transparent and reproducible approach for identifying relevant evidence, while the conceptual framework component enables the development of a unified Nano–Bio–AI architecture that illustrates how nanoscale engineering, biological systems, and computational intelligence interact to support intelligent biomedical and environmental solutions. This hybrid design is appropriate because the objective of the study is not to evaluate a single experimental system but to consolidate interdisciplinary knowledge into a coherent framework that can guide future research and practical implementation.
• The research was conducted in five sequential stages: (i) systematic identification of relevant literature, (ii) study screening and eligibility assessment, (iii) extraction and thematic synthesis of key evidence, (iv) comparative analysis of nanotechnology, biotechnology, and AI applications, and (v) development of the proposed Nano–Bio–AI conceptual framework. The overall methodological workflow is illustrated using the PRISMA study selection process and the framework development procedure described in subsequent sections.

Literature Search Strategy

A systematic literature search was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines to ensure methodological transparency and reproducibility. Four major scientific databases were searched: Scopus, Web of Science, PubMed, and IEEE Xplore, as they collectively provide comprehensive coverage of biomedical engineering, nanotechnology, biotechnology, artificial intelligence, and environmental sciences.

The literature search covered publications from January 2018 to March 2026, capturing recent advances in the convergence of nanotechnology, biotechnology, and AI. Searches were restricted to peer-reviewed journal articles published in English.

Searches were performed using Boolean operators and combinations of relevant keywords. The principal search string was:

("nanotechnology" OR nanoparticle OR nanomaterial) AND ("biotechnology" OR synthetic biology OR biosensor OR gene editing) AND ("artificial intelligence" OR "machine learning" OR "deep learning") AND (biomedical OR healthcare OR environmental OR remediation)

Additional database-specific search terms were employed where necessary to improve retrieval while maintaining consistency with the study objectives. Reference lists of selected articles were also manually screened to identify additional relevant publications that met the eligibility criteria.

The retrieved records were exported into a reference management system, where duplicate records were removed before the screening and eligibility assessment stages. The complete study selection procedure is presented in the PRISMA flow diagram described in Section 3.4.

Eligibility Criteria

Studies were selected using predefined inclusion and exclusion criteria to ensure consistency, relevance, and scientific quality. Only studies directly addressing the integration or application of nanotechnology, biotechnology, and/or artificial intelligence in biomedical or environmental contexts were considered.

Table 1: Eligibility Criteria

These criteria ensured that only scientifically credible and relevant studies were included in the evidence synthesis while minimizing selection bias.

Study Selection Process

The study selection process followed the PRISMA 2020 framework to ensure transparency and reproducibility. Records identified from the selected databases were exported to a reference management system, where duplicate entries were automatically detected and removed.

The remaining studies underwent a two-stage screening process. First, titles and abstracts were reviewed to determine their relevance to the objectives of the study. Articles that clearly failed to meet the eligibility criteria were excluded at this stage. Second, the full texts of potentially eligible studies were assessed against the predefined inclusion and exclusion criteria.

Studies meeting all eligibility requirements were included in the final qualitative synthesis and subsequently used to develop the proposed Nano–Bio–AI conceptual framework. The complete identification, screening, eligibility assessment, and inclusion process is summarized using a PRISMA 2020 flow diagram, providing a transparent account of the literature selection procedure [21].

Data Extraction

A standardized data extraction procedure was employed to ensure consistent collection of information from the selected studies. Relevant information was systematically extracted into a structured evidence matrix for comparative analysis and thematic synthesis.

The following variables were extracted from each study:

1. Author(s) and year of publication.
2. Study objective and application domain.
3. Nanotechnology component (e.g., nanoparticles, nanosensors, nanocarriers).
4. Biotechnology component (e.g., synthetic biology, biosensors, gene editing, microbial systems).
5. Artificial intelligence technique (e.g., machine learning, deep learning, neural networks, predictive analytics)
6. Biomedical or environmental application.
7. Validation approach employed by the study.
8. Principal findings and reported limitations

The extracted information formed the basis for identifying recurring technological interactions, complementary functionalities, implementation challenges, and emerging research trends. These synthesized findings subsequently informed the development of the proposed Nano–Bio–AI conceptual framework.

Quality Assessment

To enhance methodological rigor, the methodological quality and relevance of the included studies were assessed using a structured appraisal framework adapted for interdisciplinary technology reviews. Each study was evaluated across four criteria:

• Methodological clarity.
• Scientific relevance to Nano–Bio–AI integration.
• Evidence quality and reliability.
• Contribution to conceptual framework development

Each criterion was assessed using a three-point rating scale (1 = low, 2 = moderate, 3 = high). Studies demonstrating high methodological quality and strong relevance to the objectives of the review were given greater emphasis during evidence synthesis and framework development. Rather than excluding studies solely based on quality scores, the assessment was used to strengthen interpretation of the findings and to ensure that the proposed framework was primarily informed by robust and well-documented scientific evidence.

Comparative Analytical Framework

A comparative analytical framework was developed to systematically evaluate the complementary roles of nanotechnology, biotechnology, and artificial intelligence within integrated biomedical and environmental systems. Rather than assessing each technology independently, the framework examines their relative strengths and synergistic interactions using a common set of evaluation criteria derived from the reviewed literature.

The comparative evaluation considered six principal dimensions: diagnostic sensitivity, predictive capability, adaptability, scalability, implementation complexity, and sustainability. Each technology was qualitatively assessed using evidence synthesized from the included studies and comparatively analysed to identify areas of complementarity and integration.

To provide a structured basis for comparison, a conceptual Technology Integration Score (TIS) was proposed:

[TIS= \sum_{i=1}^{n}w_iS_i]

where (S_i) represents the performance score assigned to criterion i, and (w_i) represents the relative importance (weight) of that criterion. Although no empirical weighting was performed in the present study, the scoring framework provides a reproducible analytical model that can be operationalized and validated in future experimental investigations.

The comparative analysis informed the identification of functional interactions among the three technological domains and served as the foundation for the development of the proposed Nano–Bio–AI framework.

Framework Development

The proposed Nano–Bio–AI framework was developed through thematic synthesis of the evidence extracted from the selected studies. Following data extraction and quality assessment, recurring concepts, technological interactions, and functional relationships were identified through iterative comparison of the reviewed literature.

Studies were coded according to four principal analytical themes:

• Data acquisition and sensing technologies.
• Artificial intelligence and computational intelligence.
• Nanotechnology-enabled physical interfaces.
• Biotechnology-driven biological response mechanisms

The coded themes were subsequently integrated to identify common patterns describing how nanoscale engineering, biological systems, and artificial intelligence interact within biomedical and environmental applications. These recurring relationships formed the basis of the layered Nano–Bio–AI architecture proposed in this study [22].

Rather than representing an empirically validated engineering system, the framework is a theory-driven conceptual model that synthesizes current scientific knowledge into a unified interdisciplinary architecture capable of guiding future computational, experimental, and translational research.

Integration Model

The Nano–Bio–AI framework is organized as a layered integration architecture comprising four functional components: data acquisition, computational intelligence, physical intervention, and biological response. These components interact through a continuous adaptive feedback mechanism that supports intelligent decision-making in biomedical and environmental systems.

The system begins with the acquisition of biological or environmental data through nanosensors, imaging platforms, sequencing technologies, and environmental monitoring devices. These multidimensional data are processed by artificial intelligence algorithms responsible for feature extraction, predictive modelling, optimization, and decision support.

The resulting computational outputs guide nanotechnology-enabled interventions, including targeted drug delivery, molecular detection, controlled release systems, or pollutant capture mechanisms. Biotechnology subsequently provides the biological interface by facilitating cellular responses, molecular engineering, gene regulation, or microbial adaptation based on the recommended intervention.

System outputs are continuously monitored and returned to the AI layer through an adaptive feedback mechanism, allowing iterative optimization of subsequent predictions and interventions. This closed-loop architecture enables dynamic system learning while defining clear system inputs, outputs, operational boundaries, and functional interactions among the three technological domains.

Validation Strategy

Because this study is conceptual rather than experimental, validation was undertaken through evidence triangulation and comparative synthesis of representative studies identified during the systematic review. The proposed Nano–Bio–AI framework was evaluated by examining its consistency with published evidence across biomedical and environmental applications.

Validation focused on four dimensions:

• Improvement in diagnostic and predictive performance.
• Enhancement of targeted therapeutic and drug discovery processes.
• Effectiveness of environmental monitoring and remediation strategies.
• Consistency of functional interactions among nanotechnology, biotechnology, and artificial intelligence reported across independent studies.

Representative case studies drawn from the reviewed literature were used to demonstrate the applicability of the framework across multiple domains. Accordingly, the present study provides conceptual validation through systematic evidence synthesis rather than empirical or experimental validation, thereby establishing a foundation for future computational modelling, simulation studies, and laboratory investigations.

RESULTS AND DISCUSSION

The analysis of the integrated Nano–Bio–AI framework demonstrates significant synergistic potential across biomedical and environmental applications. The findings derived from literature synthesis and comparative evaluation indicate that the convergence of nanotechnology, biotechnology, and artificial intelligence (AI) leads to improved system performance, higher precision in biomedical operations, and enhanced sustainability outcomes [23]. The results are discussed under key functional domains to highlight the effectiveness of the proposed framework.

Overview of the Literature Synthesis

The systematic review identified a substantial body of interdisciplinary research examining the individual and combined applications of nanotechnology, biotechnology, and artificial intelligence in biomedical and environmental sciences. The synthesized evidence demonstrates an increasing research emphasis on integrating these technologies to overcome limitations associated with standalone approaches. The reviewed studies consistently indicate that nanotechnology provides highly sensitive sensing and delivery platforms, biotechnology contributes biologically responsive and adaptive systems, while artificial intelligence enhances predictive modelling, data interpretation, and decision support.

The literature further reveals that integration is most advanced in precision medicine, intelligent drug delivery, disease diagnostics, and environmental monitoring. Although relatively few studies report complete Nano–Bio–AI implementations, the collective evidence supports the feasibility of a unified interdisciplinary framework capable of improving efficiency, accuracy, and adaptability across multiple application domains [24-28].

Comparative Analysis of Technology Contributions

Comparative analysis of the reviewed literature demonstrates that each technological domain contributes distinct yet complementary capabilities to integrated biomedical and environmental systems.

Table 2: Comparative Contributions of Nanotechnology, Biotechnology, and Artificial Intelligence

The comparison demonstrates that no single technology independently addresses all biomedical or environmental challenges. Instead, the reviewed studies consistently indicate that combining nanoscale engineering, biological functionality, and computational intelligence produces synergistic improvements in system performance. These complementary characteristics provide the theoretical basis for the proposed Nano–Bio–AI framework [29-32].

Biomedical Applications

The reviewed studies consistently demonstrate that Nano–Bio–AI integration enhances diagnostic precision, therapeutic effectiveness, and drug discovery efficiency. Nanotechnology enables highly sensitive biosensing platforms capable of detecting disease biomarkers at extremely low concentrations, while biotechnology provides molecular specificity through bio-responsive materials, engineered cells, and genetic technologies. Artificial intelligence complements these capabilities by analysing large-scale biomedical datasets, identifying complex disease patterns, and supporting clinical decision-making through predictive modelling.

Evidence synthesized from the literature indicates particularly strong applications in precision oncology, intelligent drug delivery, infectious disease diagnosis, and personalized medicine. AI-assisted optimization of nanoparticle characteristics further improves targeting efficiency and controlled drug release, thereby reducing systemic toxicity while enhancing therapeutic outcomes. Collectively, these findings support the growing role of integrated Nano–Bio–AI systems in next-generation healthcare technologies.

Environmental Applications

The literature also demonstrates substantial opportunities for Nano–Bio–AI integration in environmental monitoring and remediation. Nanomaterials provide efficient platforms for detecting and removing chemical pollutants, while biotechnology employs engineered microorganisms and enzymatic systems for biodegradation and ecosystem restoration. Artificial intelligence enhances these processes through predictive environmental modelling, pattern recognition, and optimization of remediation strategies.

Representative studies report successful applications in water quality monitoring, soil remediation, air pollution assessment, and ecosystem management. AI-assisted environmental monitoring enables continuous analysis of large environmental datasets, supporting rapid identification of pollution events and evidence-based decision-making. These findings suggest that integrated Nano–Bio–AI systems can significantly improve environmental sustainability and resource management [33-36].

Framework Interpretation and Future Implications

The synthesized evidence demonstrates that the proposed Nano–Bio–AI framework functions as a complementary integration architecture rather than a replacement for existing technologies. Artificial intelligence provides computational intelligence and adaptive decision-making, nanotechnology enables precise physical interaction with biological and environmental systems, and biotechnology supplies biological functionality and responsiveness. The interaction among these domains establishes a continuous feedback mechanism capable of supporting intelligent, adaptive, and context-specific interventions.

Despite these advances, several challenges remain, including heterogeneous data integration, limited interoperability among technological platforms, nanotoxicity concerns, algorithmic transparency, regulatory uncertainty, and the absence of standardized implementation protocols. Consequently, the proposed framework should be regarded as a conceptually validated architecture that provides a foundation for future computational simulations, laboratory investigations, and clinical or environmental field validation.

Comparative Evaluation of the Nano–Bio–AI Framework

The comparative synthesis indicates that the integration of nanotechnology, biotechnology, and artificial intelligence provides greater functional capability than the independent application of each technology. Across the reviewed studies, nanotechnology consistently contributed high sensitivity in sensing and targeted delivery, biotechnology enhanced biological specificity and adaptive responses, while artificial intelligence improved predictive accuracy, pattern recognition, and decision support.

The comparative evaluation further demonstrates that the complementary strengths of these technologies overcome many of the limitations associated with standalone approaches. For example, nanotechnology improves molecular detection but requires intelligent computational analysis for optimal interpretation of complex datasets. Similarly, biotechnology enables highly specific biological interactions but benefits from AI-driven optimization of experimental design and molecular prediction. AI, although highly effective in analysing large datasets, depends on high-quality biological and nanoscale data generated through advances in nanotechnology and biotechnology [37-39].

Collectively, these findings demonstrate that the proposed Nano–Bio–AI framework functions as an integrated interdisciplinary system in which each technological domain contributes complementary capabilities that improve overall system performance, adaptability, and scalability.

Conceptual Validation of the Proposed Framework

The proposed Nano–Bio–AI framework was conceptually validated through evidence triangulation using representative biomedical and environmental studies identified during the systematic review. Rather than relying on experimental validation, the framework was evaluated by examining whether the functional relationships proposed within the architecture were consistently supported across independent studies.

In biomedical applications, multiple studies demonstrated that AI-assisted nanosensors improved biomarker detection while bio-responsive systems enhanced therapeutic specificity, supporting the interaction between the computational, nanoscale, and biological layers of the framework. Similarly, studies involving AI-assisted drug discovery and nanoparticle-based targeted delivery demonstrated complementary interactions that align with the proposed adaptive feedback architecture.

Environmental applications provided additional support for the framework. Studies involving nanomaterial-based pollutant detection, microbial biodegradation, and AI-assisted environmental modelling consistently demonstrated improved monitoring accuracy and remediation efficiency when these technologies were integrated. The convergence of evidence across different application domains therefore supports the conceptual coherence and practical relevance of the proposed framework while highlighting the need for future computational and experimental validation.

Implications for Research and Practice

The findings of this review have important implications for interdisciplinary research, healthcare innovation, and environmental management. From a research perspective, the proposed Nano–Bio–AI framework provides a structured foundation for integrating computational intelligence with biological and nanoscale systems. The framework may serve as a reference architecture for future computational modelling, simulation studies, laboratory experimentation, and translational research.

For healthcare applications, the framework highlights opportunities to improve precision medicine through intelligent diagnostics, personalized therapeutics, and accelerated drug discovery. The integration of AI with nanotechnology-enabled biosensors and biotechnology-based therapeutic systems has the potential to enhance clinical decision-making while reducing treatment costs and improving patient outcomes.

In environmental science, the framework supports the development of intelligent monitoring systems capable of real-time pollutant detection, predictive environmental modelling, and adaptive remediation strategies. The integration of AI with nanomaterials and engineered biological systems offers promising opportunities for sustainable environmental management and climate resilience.

Despite these opportunities, successful implementation will require internationally harmonized regulatory standards, robust ethical governance, interoperable data infrastructures, and multidisciplinary collaboration among researchers, clinicians, engineers, environmental scientists, and policymakers.

CONCLUSION

This study developed a Nano–Bio–AI conceptual framework through a PRISMA-guided systematic literature review to examine the convergence of nanotechnology, biotechnology, and artificial intelligence for advanced biomedical and environmental applications. The synthesized evidence demonstrates that integrating these complementary technological domains offers significant opportunities for improving diagnostic accuracy, targeted therapeutics, drug discovery, environmental monitoring, and sustainable remediation.

The review indicates that nanotechnology provides precise sensing and targeted delivery capabilities, biotechnology contributes biologically responsive and adaptive systems, and artificial intelligence enhances predictive analytics, optimization, and intelligent decision-making. Collectively, these technologies form an integrated architecture capable of supporting precision medicine and intelligent environmental management more effectively than isolated technological approaches.

The proposed Nano–Bio–AI framework should be regarded as a conceptually developed model derived from systematic evidence synthesis rather than an empirically validated engineering system. Its principal contribution lies in providing a structured interdisciplinary architecture that consolidates current knowledge and identifies the functional relationships among the three technological domains. The framework also incorporates governance considerations, including AI transparency, nanomaterial safety, biosafety, and regulatory compliance, which are essential for responsible implementation.

Despite the promising findings, several challenges remain. These include heterogeneous data integration, interoperability across computational and biological platforms, nanotoxicity, algorithmic bias, ethical governance, and the absence of standardized implementation protocols. Addressing these challenges will require sustained collaboration among biomedical scientists, engineers, computer scientists, environmental researchers, and policymakers.

Future research should focus on computational modelling, simulation studies, laboratory experimentation, clinical validation, and environmental field applications to evaluate the operational performance of the proposed framework. In addition, the development of standardized evaluation metrics and internationally harmonized governance frameworks will facilitate the safe translation of Nano–Bio–AI systems from conceptual models into practical biomedical and environmental technologies.

Beyond synthesizing current knowledge, this study contributes to the literature by providing a structured conceptual architecture that explicitly defines the functional interactions among nanotechnology, biotechnology, and artificial intelligence. By integrating evidence across multiple scientific disciplines using a transparent systematic review methodology, the proposed framework offers a reproducible foundation for future computational modelling, experimental validation, and translational applications. Consequently, it serves not only as a synthesis of existing research but also as a strategic roadmap for advancing interdisciplinary innovation in biomedical and environmental systems.

Overall, the proposed Nano–Bio–AI framework provides a comprehensive theoretical foundation for future interdisciplinary research and offers a structured pathway toward the development of intelligent, adaptive, and sustainable biomedical and environmental systems.

Table 3: Literature Search Strategy

Table 4: Eligibility Criteria for Study Selection

Table 5: Quality Assessment Framework

Table 6: Comparative Evaluation of Nanotechnology, Biotechnology, and Artificial Intelligence

Table 7: Technology Integration Scoring Framework

TIS = I = 1∑nwiSi

Table 8: Components of the Proposed Nano–Bio–AI Framework

Table 9: Representative Literature Supporting the Nano–Bio–AI Framework

Table 10: Conceptual Validation of the Nano–Bio–AI Framework

Table 11: Ethical and Governance Framework

Table 12: Challenges, Limitations, and Future Research Priorities

ETHICAL AND GOVERNANCE CONSIDERATIONS

Ethical, regulatory, and safety considerations were incorporated as integral components of the proposed Nano–Bio–AI framework. Rather than treating ethics as a separate discussion, the framework recognizes governance requirements as operational constraints influencing the design, implementation, and deployment of integrated intelligent systems.

Four principal governance dimensions were considered:

• Artificial intelligence governance, including transparency, explainability, algorithmic fairness, accountability, and protection of sensitive biomedical data.
• Nanotechnology safety, including nanotoxicity assessment, biocompatibility evaluation, environmental persistence, and safe material disposal.
• Biotechnology governance, including biosafety, biosecurity, responsible genetic engineering, and containment of engineered biological systems.
• Regulatory compliance, including alignment with internationally recognized biomedical ethics principles, environmental protection regulations, and responsible innovation frameworks.

Integrating these governance considerations within the conceptual architecture promotes responsible development of Nano–Bio–AI systems and provides a foundation for future implementation under evolving international regulatory and ethical standards.